Le remboursement conditionnel : un outil pour réduire les incertitudes sur la valeur des médicaments et renforcer leur évaluation continue

In order to alleviate the inherent uncertainty that comes with the market access and public funding of new health products, a conditional reimbursement mechanism is proposed. The latter is circumscribed by recommendations regarding its implementation in limited cases in order to allow for a fair access of patients to therapeutic innovations, within economic conditions both optimum and reviewable.